FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907776942> ?p ?o ?g. }

• W2907776942 endingPage "390" @default.
• W2907776942 startingPage "379" @default.
• W2907776942 abstract "To evaluate efficacy and safety of lapatinib or trastuzumab alone or both plus chemotherapy for the treatment of breast cancer patients with positive HER-2 expression.Cochrane Central Register of Controlled Trials, PubMed, MEDLINE, OVID, Embase, Chinese Biomedical Literature Database, and China Academic Journals Database were searched from 1994 through December 2017 using the keywords breast cancer, preoperative, neo-adjuvant, lapatinib, pertuzumab, Herceptin, and trastuzumab.Meta-analysis found that pathological complete response (PCR; risk ratio [RR]=0.82, 95% CI: 0.72-0.93) and tall PCR (tPCR; RR=0.77, 95% CI: 0.67-0.88) of chemotherapy plus lapatinib were significantly less effective or safe compared to that of chemotherapy plus trastuzumab (P<0.05). PCR (RR=1.30, 95% CI: 1.15-1.47) and tPCR (RR=1.32, 95% CI: 1.16-1.50) of chemotherapy plus both lapatinib and trastuzumab were significantly superior to that of chemotherapy plus trastuzumab alone (P<0.05). However, there was no significant difference in breast reservation rate between chemotherapy plus lapatinib vs chemotherapy plus trastuzumab (RR=0.91, 95% CI: 0.72-1.16) or chemotherapy plus both lapatinib and trastuzumab (RR=1.11, 95% CI: 0.73-1.68, P>0.05). Incidence of diarrhea, hepatic toxicity, and skin rash in the groups of chemotherapy plus lapatinib or chemotherapy plus both lapatinib and trastuzumab was significantly higher than that in chemotherapy plus trastuzumab (P<0.05).Efficacy of lapatinib was less than that of trastuzumab, but incidence of adverse effect of lapatinib was higher than that of trastuzumab. Combination of chemotherapy plus both lapatinib and trastuzumab could significantly increase PCR and tPCR in breast cancer patients, but rate of breast conservation, event-free survival, and overall survival was not significantly improved. Incidence of diarrhea, hepatic toxicity, and skin rash was significantly increased in the groups using lapatinib." @default.
• W2907776942 created "2019-01-11" @default.
• W2907776942 creator A5007947547 @default.
• W2907776942 creator A5023977235 @default.
• W2907776942 creator A5029803904 @default.
• W2907776942 creator A5031315906 @default.
• W2907776942 creator A5049970272 @default.
• W2907776942 creator A5063195620 @default.
• W2907776942 creator A5067483315 @default.
• W2907776942 date "2019-01-01" @default.
• W2907776942 modified "2023-09-23" @default.
• W2907776942 title "Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis" @default.
• W2907776942 cites W1955397179 @default.
• W2907776942 cites W1971267920 @default.
• W2907776942 cites W1979563875 @default.
• W2907776942 cites W1980390953 @default.
• W2907776942 cites W2012784647 @default.
• W2907776942 cites W2043506695 @default.
• W2907776942 cites W2046958698 @default.
• W2907776942 cites W2054670033 @default.
• W2907776942 cites W2055235037 @default.
• W2907776942 cites W2058191095 @default.
• W2907776942 cites W2070264012 @default.
• W2907776942 cites W2075894019 @default.
• W2907776942 cites W2089288294 @default.
• W2907776942 cites W2093322080 @default.
• W2907776942 cites W2095865154 @default.
• W2907776942 cites W2099005045 @default.
• W2907776942 cites W2111578514 @default.
• W2907776942 cites W2120661754 @default.
• W2907776942 cites W2125239609 @default.
• W2907776942 cites W2129695292 @default.
• W2907776942 cites W2145191585 @default.
• W2907776942 cites W2145477245 @default.
• W2907776942 cites W2154277980 @default.
• W2907776942 cites W2155560234 @default.
• W2907776942 cites W2162982444 @default.
• W2907776942 cites W2166199281 @default.
• W2907776942 cites W2168111658 @default.
• W2907776942 cites W2264655007 @default.
• W2907776942 cites W2318605753 @default.
• W2907776942 cites W2624590002 @default.
• W2907776942 cites W2782303571 @default.
• W2907776942 cites W2853312207 @default.
• W2907776942 cites W2887131751 @default.
• W2907776942 cites W2892163061 @default.
• W2907776942 cites W4233498657 @default.
• W2907776942 cites W4245606248 @default.
• W2907776942 doi "https://doi.org/10.2147/ott.s183304" @default.
• W2907776942 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6322707" @default.
• W2907776942 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30655674" @default.
• W2907776942 hasPublicationYear "2019" @default.
• W2907776942 type Work @default.
• W2907776942 sameAs 2907776942 @default.
• W2907776942 citedByCount "5" @default.
• W2907776942 countsByYear W29077769422020 @default.
• W2907776942 countsByYear W29077769422021 @default.
• W2907776942 countsByYear W29077769422022 @default.
• W2907776942 crossrefType "journal-article" @default.
• W2907776942 hasAuthorship W2907776942A5007947547 @default.
• W2907776942 hasAuthorship W2907776942A5023977235 @default.
• W2907776942 hasAuthorship W2907776942A5029803904 @default.
• W2907776942 hasAuthorship W2907776942A5031315906 @default.
• W2907776942 hasAuthorship W2907776942A5049970272 @default.
• W2907776942 hasAuthorship W2907776942A5063195620 @default.
• W2907776942 hasAuthorship W2907776942A5067483315 @default.
• W2907776942 hasBestOaLocation W29077769421 @default.
• W2907776942 hasConcept C121608353 @default.
• W2907776942 hasConcept C126322002 @default.
• W2907776942 hasConcept C143998085 @default.
• W2907776942 hasConcept C197934379 @default.
• W2907776942 hasConcept C2776694085 @default.
• W2907776942 hasConcept C2777329042 @default.
• W2907776942 hasConcept C2779786085 @default.
• W2907776942 hasConcept C2781164504 @default.
• W2907776942 hasConcept C530470458 @default.
• W2907776942 hasConcept C71924100 @default.
• W2907776942 hasConcept C95190672 @default.
• W2907776942 hasConceptScore W2907776942C121608353 @default.
• W2907776942 hasConceptScore W2907776942C126322002 @default.
• W2907776942 hasConceptScore W2907776942C143998085 @default.
• W2907776942 hasConceptScore W2907776942C197934379 @default.
• W2907776942 hasConceptScore W2907776942C2776694085 @default.
• W2907776942 hasConceptScore W2907776942C2777329042 @default.
• W2907776942 hasConceptScore W2907776942C2779786085 @default.
• W2907776942 hasConceptScore W2907776942C2781164504 @default.
• W2907776942 hasConceptScore W2907776942C530470458 @default.
• W2907776942 hasConceptScore W2907776942C71924100 @default.
• W2907776942 hasConceptScore W2907776942C95190672 @default.
• W2907776942 hasLocation W29077769421 @default.
• W2907776942 hasLocation W29077769422 @default.
• W2907776942 hasLocation W29077769423 @default.
• W2907776942 hasLocation W29077769424 @default.
• W2907776942 hasLocation W29077769425 @default.
• W2907776942 hasOpenAccess W2907776942 @default.
• W2907776942 hasPrimaryLocation W29077769421 @default.
• W2907776942 hasRelatedWork W2061349734 @default.
• W2907776942 hasRelatedWork W2070897543 @default.

• next